CTRI/2016/01/006519招募中4 期
â??CLINICAL EVALUATION OF EFFICACY AND SAFETY OF THREE DIFFERENT DOSES OF FENTANYL TO PREVENT HAEMODYNAMIC STRESS RESPONSE DURING LARYNGOSCOPY AND INTUBATION: A RANDOMIZED DOUBLE BLIND CLINICAL STUDYâ??
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age: 18 to 40 years.
- •Gender: Either gender.
- •Patients posted for elective surgery under general anaesthesia requiring endotracheal intubation.
- •Duration of surgery up to 2 hrs.
- •ASA physical status I and II.
- •BMI <= 25kg/m2.
- •Informed written consent for participation in study.
排除标准
- •Patients with diabetes, COPD, renal disease, cardiac diseases like IHD, hypertension, valvular heart disease, AV conduction block, aortic stenosis, left ventricular failure, etc.
- •Patients on drugs having effects on heart rate and blood pressure (sedatives, opioids, β-blockers, calcium channel blockers, diuretics) and anti-psychiatric drugs.
- •Pregnant women and lactating mothers.
- •Anticipated difficult intubation.
- •Intubation attempt lasting longer than 15 seconds.
研究者
相似试验
尚未招募
3 期
Effect of tranexamic acid and aprotinin in absolute blood loss in pediatric neurosurgeryIRCT20200705048023N1Tehran University of Medical Sciences90
已完成
不适用
The evaluation of the efficacy and the safety of TSUMURA Tokishakuyakusan Extract Granules for Ethical Use on endometriosis patients with dysmenorrheaEndometriosisJPRN-UMIN000017908Tottori University Faculty of Medicine15
招募中
2 期
Assessment of pomegranate whitening cream on melasmaChloasmaIRCT20161207031288N6Tehran University of Medical Sciences20
进行中（未招募）
4 期
Safety and effectiveness clinical evaluation of the range of injectable hyaluronic acid medical devices in facial aesthetic treatmentModerate to severe peri-oral lines, moderate to severe nasolabial folds, moderate to severe cheeks/cheekbones volume deficit, chin recursionSkin and Connective Tissue DiseasesISRCTN49836437Kylane Laboratoires SA68
已完成
不适用
Clinical Evaluation of Safety and Performance of the BackBeat Moderato System1000752110057166HypertensionNL-OMON40595BackBeat Medical, Inc.10